跳至主要内容
临床试验/NCT01830283
NCT01830283Unknown4 期

Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination

Beijing Center for Disease Control and Prevention1 个研究点 分布在 1 个国家目标入组 50,000 人开始时间: 2013年4月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
50,000
试验地点
1
主要终点
Incidence of varicella after 2 dose vaccination

研究概览

简要总结

To investigate the safety, immunogenicity and immune effect of the Varicella vaccine after the 2nd dose vaccination in Chao yang district, Bei jing, since the 2nd varicella vaccination was promoted by Beijing Center for Disease Control and Prevention in November, 2012.

详细描述

"Breakthrough" varicella cases and varicella cases were monitored to evaluate the protective effective in a large population.

Make the basic evaluation of safety for the two dose of varicella vaccination

Monitoring the Varicella virus origin and virus types from illness cases in Chao yang district

Make the evaluation of healthy costs reduce for the varicella emergency vaccination after large number of varicella cases occurred.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
4 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Participants were between 4-12 years old
  • Participants were in good healthy determined through medical history, physical examination, clinical judgment of the investor

排除标准

  • Having a fever (axillary temperature >37.0℃) before enrollment;
  • Having a disease history of seizures, brain and mental disease and the vaccination history of allergies and convulsions;
  • Antibiotics allergy;
  • Having a problem of intramuscular injection because thrombocytopenia or other blood coagulation disorder;
  • Having immunodeficiency or under immunosuppression therapy, radiation therapy;
  • Having respiratory diseases, acute infection, chronic disease and HIV infection;
  • Having systemic skin rash, skin tinea, herpes;
  • Chronic liver and kidney disease;
  • Heart disease, and severe hypertension;
  • Have received whole blood, plasma or immunoglobulin therapy 3 months before enrollment;
  • Have not received other vaccination in 7 days before enrollment

结局指标

主要结局

Incidence of varicella after 2 dose vaccination

时间窗: 5 years

Detection the Varicella virus origin and virus types from illness cases in Chao yang district

次要结局

  • Adverse event rate of varicella vaccine after 2 dose injection(5 years)

研究者

发起方
Beijing Center for Disease Control and Prevention
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验